Presenter:
Phillip H. Kuo, MD, PhD, FACR, Consultant, Perceptive Imaging
Dr. Kuo is an internationally recognized physician-scientist. He played a pivotal role in the landmark VISION trial with Endocyte and Novartis, leading imaging eligibility design and quantitative PSMA PET analytics using AI. His academic career spans molecular imaging, MR, and radiopharmaceutical development, with notable contributions in dopaminergic imaging and neuro-oncologic theranostics. Dr. Kuo is deeply engaged in Alzheimer’s research, shaping appropriate use criteria and procedural guidelines. He has authored over 140 peer-reviewed publications and continues to advance innovation in imaging and therapeutic development globally.
